Showing 19,721 - 19,740 results of 117,914 for search '(( a mean decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.62s Refine Results
  1. 19721
  2. 19722
  3. 19723
  4. 19724
  5. 19725

    DataSheet_1_Effect of sustained decreases in sedentary time and increases in physical activity on liver enzymes and indices in type 2 diabetes.docx by Jonida Haxhi (552548)

    Published 2024
    “…This study assessed whether a counseling intervention for increasing PA and decreasing sedentary time (SED-time) is effective in improving NAFLD markers in people with type 2 diabetes.…”
  6. 19726

    Porosity and Mean pore size of porous NiTi alloy samples. by Yu-Tao Jian (750145)

    Published 2015
    “…From group A to E the MPS decreases with the descending size of the added NH<sub>4</sub>HCO<sub>3</sub>.…”
  7. 19727

    Population-level mean antibody (Ab) responses for the protein microarray data. by John Joseph Valletta (564020)

    Published 2017
    “…<p>A: Mean antibody responses stratified by age (2-10y vs. 18-25y, top) or immune status (protected vs. susceptible, bottom) and sorted by decreasing intensity of one of the strata (old individuals, top, and protected individuals, bottom); each dot represents the mean response to an individual antigen. …”
  8. 19728
  9. 19729

    Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

    Published 2023
    “…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”
  10. 19730

    Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

    Published 2023
    “…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”
  11. 19731

    Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

    Published 2023
    “…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”
  12. 19732

    Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

    Published 2023
    “…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”
  13. 19733

    Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

    Published 2023
    “…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”
  14. 19734

    Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

    Published 2023
    “…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”
  15. 19735

    Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

    Published 2023
    “…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”
  16. 19736

    Decreased <i>Bgl-</i>FaNaC expression in the left parietal ganglion following <i>S</i>. <i>mansoni</i> infection. by Laura C. Vicente-Rodríguez (16437803)

    Published 2023
    “…<p><b>a-c:</b> Decreased <i>Bgl</i>-FaNaC hybridization on the dorsal surface of the left parietal ganglion in infected specimens. …”
  17. 19737

    Model results for green turtles and monthly mean maximum air temperature. by Jaylene Flint (4330021)

    Published 2017
    “…<p>↑ denotes increased strandings rates with increased mean maximum air temperature. ↓ denotes decreased stranding rates with increased mean maximum air temperature. …”
  18. 19738

    Model results for green turtles and monthly mean minimum air temperature. by Jaylene Flint (4330021)

    Published 2017
    “…<p>↑ denotes increased strandings rates with increased mean minimum air temperature. ↓ denotes decreased stranding rates with increased mean minimum air temperature. …”
  19. 19739

    The <i>Listeria</i> Small RNA Rli27 Regulates a Cell Wall Protein inside Eukaryotic Cells by Targeting a Long 5′-UTR Variant by Juan J. Quereda (651911)

    Published 2014
    “…The 234-nucleotide 5′-UTR is also the target of a small RNA (sRNA) denoted Rli27, which we identified by bioinformatics analysis as having extensive base pairing potential with the long 5′-UTR. …”
  20. 19740

    A BMP7 Variant Inhibits Tumor Angiogenesis <i>In Vitro</i> and <i>In Vivo</i> through Direct Modulation of Endothelial Cell Biology by Courtney M. Tate (555115)

    Published 2015
    “…Importantly, in an <i>in vivo</i> angiogenic plug assay that serves as a measurement of angiogenesis, BMP7v significantly decreased hemoglobin content indicating inhibition of neoangiogenesis. …”